Relizen®, a Natural, Non-Estrogenic Therapy for Hot Flashes Associated with Menopause, Launches in the U.S.

JDS Therapeutics Announces U.S. Launch of Physician Recommended Relizen®, a Safe, Natural Therapy for Hot Flashes

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Relizen is supported by numerous studies demonstrating no estrogenic effect, making it a natural treatment option available for women in Europe and now the United States.

Los Angeles (PRWEB) August 05, 2014

Relizen®†, a patented, non-hormonal nutritional supplement for the relief of hot flashes associated with menopause, is now available to U.S. consumers for purchase at Relizen.com.

Over 43 million women are of menopausal age in the United States. Seventy-five percent of women report experiencing hot flashes, and 87 percent of these women experience this common symptom on a daily basis.(1,2) These women now have access to a safe and natural therapy that is non-hormonal, non-estrogenic, and is endorsed by gynecologists for women suffering from hot flashes associated with menopause.

Clinically shown to reduce hot flashes, Relizen has been used by over one million women in Europe over the last 15 years. Relizen is one of France’s leading menopause products.

Unlike products that use soy or other phytoestrogens, Relizen is a unique, plant-based therapy for the relief of hot flashes that is non-estrogenic and effective in clinical trials. According to a placebo-controlled clinical trial published in Climacteric, a peer-reviewed medical journal, Relizen produced a significant reduction in hot flashes without changing women’s hormone levels compared to placebo. In the same study, Relizen also reduced tiredness, decreased mood swings, and improved overall quality of life in women going through menopause.(3) Relizen also improved quality of life in a survey of over 400 women. After 3 months of Relizen usage, 93% of women reported that Relizen was very effective or quite effective in reducing symptoms of menopause.(4)

“We believe women should have natural solutions to menopausal symptoms. Relizen underscores our commitment to providing scientifically backed, natural approaches to consumers’ healthcare needs, and we are excited to launch this product in the United States,” said Michael Satow, CEO of JDS Therapeutics, the makers of Relizen. “Relizen is supported by numerous studies demonstrating no estrogenic effect, making it a natural treatment option available for women in Europe and now the United States.”

For more information about Relizen, please visit Relizen.com.

About JDS Therapeutics
JDS Therapeutics markets proprietary, high-quality healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. JDS is focused on providing patients with scientifically backed, natural approaches to meeting their healthcare needs, and owns more than 100 issued or pending patents worldwide involving clinically active natural compounds.

† Relizen® is a registered trademark of JDS Therapeutics, LLC.

(1) ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202-16.
(2) ACOG "Frequently Asked Questions on Women's Health" Accessed July 31, 2014. Link
(3) Winther K, Rein E, Hedman C. [Relizen]—herbal remedy made from pollen extracts, reduces hot flashes and improves quality of life in menopausal women: a randomized, placebo-controlled, parallel study. Climacteric. 2005;8: 162-170.
(4) Elia D, Mares P. Assessment of the tolerance and effectiveness of a food supplement [Relizen] for menopausal women. Genesis. 2008;135:12-15.


Contact

  • Elizabeth Maxim
    Marketing Maven
    +1 (310) 994-7381
    Email

Attachments